In mice with ova-induced bronchial asthma, the administration of EGCG via tail vein injection demonstrates a notable amelioration of asthma symptoms, along with a reduction in lung infiltration of inflammatory cells and levels of inflammatory factors IL-2, IL-6, and TNF-α. Here, TNF is linked to asthma.